News Announcement

Orchid Pharma: Outcome Of Board Meeting Held For Considering And Approving Revised Audited Financial Results For The Year Ended March 31 2026 Pursuant To Scheme Of Merger.

Revised Audited financial results for the Financial year ended March 31 2026 pursuant to Scheme of Merger

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan